INIS
patients
100%
anticoagulants
79%
thrombin
50%
plasma
49%
risks
47%
reviews
43%
laboratories
41%
comparative evaluations
38%
concentration
38%
drugs
35%
assessments
34%
proteins
30%
data
30%
testing
29%
evaluation
27%
heparin
26%
levels
26%
diseases
24%
doses
21%
antibodies
21%
control
21%
values
21%
inhibition
20%
performance
19%
thrombosis
19%
administration
18%
monitoring
18%
sensitivity
18%
applications
18%
in vitro
17%
tyrosine
17%
nanoparticles
17%
kinases
17%
covid-19
16%
screening
16%
blood
15%
reagents
15%
safety
15%
vaccines
15%
receptors
15%
cancer
15%
humans
14%
information
14%
rats
14%
validation
14%
biological markers
13%
women
13%
in vivo
13%
synthesis
12%
molecular weight
12%
vitamin k
12%
inflammation
12%
emergencies
12%
therapy
11%
myeloid leukemia
11%
detection
11%
neutrophils
11%
toxicity
11%
estrogens
10%
production
10%
coronaviruses
10%
design
10%
range
10%
standardization
10%
surgery
10%
recommendations
9%
interactions
9%
management
9%
mass spectrometry
9%
tissues
9%
venoms
8%
hemostatics
8%
endothelium
7%
accuracy
7%
molecules
7%
populations
7%
adhesion
7%
lungs
6%
capacity
6%
reduction
6%
medicines
6%
kidneys
6%
peaks
6%
dimers
6%
wave forms
6%
prothrombin
6%
thromboplastin
6%
hormones
5%
substrates
5%
ligands
5%
hemolysis
5%
metabolism
5%
symptoms
5%
liquids
5%
stability
5%
aggregation
5%
lipids
5%
economics
5%
nucleosomes
5%
migration
5%
Keyphrases
Direct Oral Anticoagulants
5%
Disproportionality Analysis
5%